Global (United States, European Union and China) Therapeutic Vaccines Market Research Report 2019-2025

Table of Contents

1 Therapeutic Vaccines Market Overview

• 1.1 Product Overview and Scope of Therapeutic Vaccines
• 1.2 Therapeutic Vaccines Segment by Type
  • 1.2.1 Global Therapeutic Vaccines Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Peptide Therapeutic Vaccine
  • 1.2.3 Cell Therapeutic Vaccine
  • 1.2.4 Nucleic Acid Therapeutic Vaccine
• 1.3 Therapeutic Vaccines Segment by Application
  • 1.3.1 Therapeutic Vaccines Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Oncotherapy
  • 1.3.3 Hepatitis B
  • 1.3.4 Tuberculosis
  • 1.3.5 Herpes Simplex Virus
  • 1.3.6 Others
• 1.4 Global Therapeutic Vaccines Market Size Estimates and Forecasts
  • 1.4.1 Global Therapeutic Vaccines Revenue 2015-2026
  • 1.4.2 Global Therapeutic Vaccines Sales 2015-2026
  • 1.4.3 Therapeutic Vaccines Market Size by Region: 2020 Versus 2026

2 Global Therapeutic Vaccines Market Competition by Manufacturers

• 2.1 Global Therapeutic Vaccines Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Therapeutic Vaccines Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Therapeutic Vaccines Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Therapeutic Vaccines Manufacturing Sites, Area Served, Product Type
• 2.5 Therapeutic Vaccines Market Competitive Situation and Trends
  • 2.5.1 Therapeutic Vaccines Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Therapeutic Vaccines Players (Opinion Leaders)

3 Therapeutic Vaccines Retrospective Market Scenario by Region

• 3.1 Global Therapeutic Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Therapeutic Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Therapeutic Vaccines Market Facts & Figures by Country
  • 3.3.1 North America Therapeutic Vaccines Sales by Country
  • 3.3.2 North America Therapeutic Vaccines Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Therapeutic Vaccines Market Facts & Figures by Country
  • 3.4.1 Europe Therapeutic Vaccines Sales by Country
  • 3.4.2 Europe Therapeutic Vaccines Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Therapeutic Vaccines Sales by Region
  • 3.5.2 Asia Pacific Therapeutic Vaccines Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Therapeutic Vaccines Market Facts & Figures by Country
  • 3.6.1 Latin America Therapeutic Vaccines Sales by Country
  • 3.6.2 Latin America Therapeutic Vaccines Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Therapeutic Vaccines Sales by Country
  • 3.7.2 Middle East and Africa Therapeutic Vaccines Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Therapeutic Vaccines Historic Market Analysis by Type

• 4.1 Global Therapeutic Vaccines Sales Market Share by Type (2015-2020)
• 4.2 Global Therapeutic Vaccines Revenue Market Share by Type (2015-2020)
• 4.3 Global Therapeutic Vaccines Price Market Share by Type (2015-2020)
• 4.4 Global Therapeutic Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Therapeutic Vaccines Historic Market Analysis by Application

• 5.1 Global Therapeutic Vaccines Sales Market Share by Application (2015-2020)
• 5.2 Global Therapeutic Vaccines Revenue Market Share by Application (2015-2020)
• 5.3 Global Therapeutic Vaccines Price by Application (2015-2020)

6 Company Profiles and Key Figures in Therapeutic Vaccines Business

• 6.1 Northeast Biotherapeutics
  • 6.1.1 Corporation Information
  • 6.1.2 Northeast Biotherapeutics Description, Business Overview and Total Revenue
  • 6.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Northeast Biotherapeutics Products Offered
  • 6.1.5 Northeast Biotherapeutics Recent Development
• 6.2 Agenus
  • 6.2.1 Agenus Therapeutic Vaccines Production Sites and Area Served
  • 6.2.2 Agenus Description, Business Overview and Total Revenue
  • 6.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Agenus Products Offered
  • 6.2.5 Agenus Recent Development
• 6.3 Vaccinogen Inc
  • 6.3.1 Vaccinogen Inc Therapeutic Vaccines Production Sites and Area Served
  • 6.3.2 Vaccinogen Inc Description, Business Overview and Total Revenue
  • 6.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Vaccinogen Inc Products Offered
  • 6.3.5 Vaccinogen Inc Recent Development
• 6.4 CIMAB S.A
  • 6.4.1 CIMAB S.A Therapeutic Vaccines Production Sites and Area Served
  • 6.4.2 CIMAB S.A Description, Business Overview and Total Revenue
  • 6.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 CIMAB S.A Products Offered
  • 6.4.5 CIMAB S.A Recent Development
• 6.5 Dendreon
  • 6.5.1 Dendreon Therapeutic Vaccines Production Sites and Area Served
  • 6.5.2 Dendreon Description, Business Overview and Total Revenue
  • 6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Dendreon Products Offered
  • 6.5.5 Dendreon Recent Development
• 6.6 Corixa
  • 6.6.1 Corixa Therapeutic Vaccines Production Sites and Area Served
  • 6.6.2 Corixa Description, Business Overview and Total Revenue
  • 6.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Corixa Products Offered
  • 6.6.5 Corixa Recent Development
• 6.7 AVAX Technologies
  • 6.6.1 AVAX Technologies Therapeutic Vaccines Production Sites and Area Served
  • 6.6.2 AVAX Technologies Description, Business Overview and Total Revenue
  • 6.6.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 AVAX Technologies Products Offered
  • 6.7.5 AVAX Technologies Recent Development

7 Therapeutic Vaccines Manufacturing Cost Analysis

• 7.1 Therapeutic Vaccines Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Therapeutic Vaccines
• 7.4 Therapeutic Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Therapeutic Vaccines Distributors List
• 8.3 Therapeutic Vaccines Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Therapeutic Vaccines Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Therapeutic Vaccines by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Therapeutic Vaccines by Type (2021-2026)
• 10.2 Therapeutic Vaccines Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Therapeutic Vaccines by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Therapeutic Vaccines by Application (2021-2026)
• 10.3 Therapeutic Vaccines Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Therapeutic Vaccines by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Therapeutic Vaccines by Region (2021-2026)
• 10.4 North America Therapeutic Vaccines Estimates and Projections (2021-2026)
• 10.5 Europe Therapeutic Vaccines Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Therapeutic Vaccines Estimates and Projections (2021-2026)
• 10.7 Latin America Therapeutic Vaccines Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Therapeutic Vaccines Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List